Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.

Louie, Thomas; Nord, Carl Erik; Talbot, George H; Wilcox, Mark; Gerding, Dale N; Buitrago, Martha; Kracker, Hilke; Charef, Pascal; Cornely, Oliver A

Louie, Thomas; Nord, Carl Erik; Talbot, George H; Wilcox, Mark; Gerding, Dale N; Buitrago, Martha; Kracker, Hilke; Charef, Pascal; Cornely, Oliver A.

Affiliation

Louie T; University of Calgary, Calgary, Alberta, Canada thomas.louie@albertahealthservices.ca.
Nord CE; Karolinska Institute, Stockholm, Sweden.
Talbot GH; Talbot Advisors, Anna Maria, Florida, USA.
Wilcox M; Leeds General Infirmary, Leeds, United Kingdom.
Gerding DN; Loyola University, Maywood, Illinois, USA.
Buitrago M; Idaho Falls Infectious Diseases, Idaho Falls, Idaho, USA.
Kracker H; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.
Charef P; Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.
Cornely OA; Department of Internal Medicine, Clinical Trials Centre Cologne, ZKS Köln, Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Antimicrob Agents Chemother ; 59(10): 6266-73, 2015 Oct.

Article in En | MEDLINE | ID: mdl-26248357

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections / Oxazolidinones / Diarrhea / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2015 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google